Cite
Andreadou I, Efentakis P, Balafas E, et al. Empagliflozin Limits Myocardial Infarction . Front Physiol. 2017;8:1077doi: 10.3389/fphys.2017.01077.
Andreadou, I., Efentakis, P., Balafas, E., Togliatto, G., Davos, C. H., Varela, A., Dimitriou, C. A., Nikolaou, P. E., Maratou, E., Lambadiari, V., Ikonomidis, I., Kostomitsopoulos, N., Brizzi, M. F., Dimitriadis, G., & Iliodromitis, E. K. (2017). Empagliflozin Limits Myocardial Infarction . Frontiers in physiology, 81077. https://doi.org/10.3389/fphys.2017.01077
Andreadou, Ioanna, et al. "Empagliflozin Limits Myocardial Infarction ." Frontiers in physiology vol. 8 (2017): 1077. doi: https://doi.org/10.3389/fphys.2017.01077
Andreadou I, Efentakis P, Balafas E, Togliatto G, Davos CH, Varela A, Dimitriou CA, Nikolaou PE, Maratou E, Lambadiari V, Ikonomidis I, Kostomitsopoulos N, Brizzi MF, Dimitriadis G, Iliodromitis EK. Empagliflozin Limits Myocardial Infarction . Front Physiol. 2017 Dec 19;8:1077. doi: 10.3389/fphys.2017.01077. eCollection 2017. PMID: 29311992; PMCID: PMC5742117.
Copy
Download .nbib